Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,473.47
(
0.37%
)
US TECH 100
29,038.40
(
1.17%
)
Dow Jones
50,579.70
(
0.58%
)
Brent Oil
95.48
(
-5.62%
)
Bitcoin
77,537.40
(
0.34%
)
News Focus
News Focus
Post# of 518777
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

McMagyar

Send PM Follow Ignore
Followers 44
Posts 10706
Boards Moderated 0
Alias Born 01/13/2016

McMagyar

Re: TTTav66 post# 148107

Wednesday, 04/18/2018 1:19:29 PM

Wednesday, April 18, 2018 1:19:29 PM

Post# of 518777

World Orphan Drug Congress USA 2018 - Conference Day One @ 11:25
Empowered educated patients influencing pre-clinical development and working with industry to optimize drug discovery
Patient groups role guiding research, disease understanding, supporting pre-clinical development and follow up experiments
Driving translational research and the influence on formulation, routes to delivery and overall clinical development
Effective partnerships between advocacy and industry to expand collaborations that can support enrollment and physician engagement
Christopher Missling, President and CEO, Anavex Life Sciences
Steven Kaminsky, Chief Science Officer, International Rett Syndrome Foundation
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AVXL News
More AVXL News